SOPHiA GENETICS SA
SOPH
$4.59
-$0.04-0.86%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 21.69M | 21.71M | 19.46M | 18.32M | 17.78M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.69M | 21.71M | 19.46M | 18.32M | 17.78M |
| Cost of Revenue | 6.94M | 7.02M | 6.56M | 6.05M | 5.57M |
| Gross Profit | 14.75M | 14.69M | 12.91M | 12.27M | 12.21M |
| SG&A Expenses | 22.57M | 24.65M | 22.56M | 22.34M | 19.13M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | 45.00K | 143.00K | -66.00K | -8.00K |
| Total Operating Expenses | 38.97M | 40.25M | 37.32M | 36.82M | 33.82M |
| Operating Income | -17.28M | -18.54M | -17.86M | -18.49M | -16.04M |
| Income Before Tax | -19.07M | -19.57M | -19.38M | -21.65M | -16.88M |
| Income Tax Expenses | 253.00K | -395.00K | 642.00K | 762.00K | 503.00K |
| Earnings from Continuing Operations | -19.32M | -19.18M | -20.02M | -22.41M | -17.39M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.32M | -19.18M | -20.02M | -22.41M | -17.39M |
| EBIT | -17.28M | -18.54M | -17.86M | -18.49M | -16.04M |
| EBITDA | -16.13M | -18.10M | -16.77M | -17.48M | -14.98M |
| EPS Basic | -0.27 | -0.28 | -0.30 | -0.33 | -0.26 |
| Normalized Basic EPS | -0.17 | -0.18 | -0.18 | -0.20 | -0.16 |
| EPS Diluted | -0.27 | -0.28 | -0.30 | -0.33 | -0.26 |
| Normalized Diluted EPS | -0.17 | -0.18 | -0.18 | -0.20 | -0.16 |
| Average Basic Shares Outstanding | 71.14M | 68.50M | 67.79M | 67.32M | 66.38M |
| Average Diluted Shares Outstanding | 71.14M | 68.50M | 67.79M | 67.32M | 66.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |